CURE Innovator Award

Funding Agency:
Citizens United for Research in Epilepsy (CURE)

The CURE Innovator Award supports the exploration of a highly innovative, often risky new concept or untested theory that addresses an important problem relevant to epilepsy. The proposed research must reflect ideas substantially different from those being pursued by anyone in the epilepsy research field. The program is not intended to support the logical progression of an already established research project but, instead, allows Principal Investigators (PIs) the opportunity to pursue radically unconventional, paradigm-shifting hypotheses. This award mechanism supports high-risk studies that have the potential to reveal entirely new areas of epilepsy research. Research completed through an Innovator Award must provide sufficient preliminary data to enable the PI to prove or disprove their groundbreaking, original, and/or unconventional hypothesis and have the potential, if the scope of work is successful, to move epilepsy research forward by leaps rather than by incremental steps. 

Deadlines for Letter of Intent: Jan. 8, 2018

Agency Website

Eligibility Requirements

This award is available to both established and early career investigators*. Researchers who serve on CURE’s Scientific Advisory Council are ineligible to apply for or sponsor a grant for the duration of their term. International applicants are welcome. All materials must be submitted in English.



Amount Description

This program awards $50,000 seed grants to researchers submitting innovative proposals that will provide new directions for epilepsy disease modifying therapies, prevention and, ultimately, a cure. We specifically encourage studies that may not be currently fundable by other agencies or other mechanisms because of their preliminary, innovative or unconventional nature.

Funding Type



Junior Faculty
Medical Fellow/Resident
Post Doctoral Fellows


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

January 8, 2018